Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Depreciation & Amortization (CF): 2019-2024

Historic Depreciation & Amortization (CF) for Aveanna Healthcare Holdings (AVAH) over the last 5 years, with FY2024 value amounting to $10.8 million.

  • Aveanna Healthcare Holdings' Depreciation & Amortization (CF) rose 46.39% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 1170.8%. This contributed to the annual value of $10.8 million for FY2024, which is 2177.38% down from last year.
  • Per Aveanna Healthcare Holdings' latest filing, its Depreciation & Amortization (CF) stood at $10.8 million for FY2024, which was down 2177.38% from $13.8 million recorded in FY2023.
  • Aveanna Healthcare Holdings' Depreciation & Amortization (CF)'s 5-year high stood at $21.3 million during FY2022, with a 5-year trough of $10.8 million in FY2024.
  • In the last 4 years, Aveanna Healthcare Holdings' Depreciation & Amortization (CF) had a median value of $17.0 million in 2021 and averaged $16.7 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 2069.07% in 2022, then tumbled by 3535.4% in 2023.
  • Over the past 4 years, Aveanna Healthcare Holdings' Depreciation & Amortization (CF) (Annual) stood at $17.0 million in 2021, then increased by 25.17% to $21.3 million in 2022, then plummeted by 35.35% to $13.8 million in 2023, then decreased by 21.77% to $10.8 million in 2024.
  • Its Depreciation & Amortization (CF) was $10.8 million in FY2024, compared to $13.8 million in FY2023 and $21.3 million in FY2022.